At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 209 enrolled
Drug / intervention
Gufoni +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
In Brief
A Phase 2 clinical trial evaluating Gufoni, Vibration, and 1 other intervention for Benign Paroxysmal Positional Vertigo. Completed, enrolled 209 participants across 1 site.
Detailed Summary
To determine the short term therapeutic efficacies of Gufoni maneuver and mastoid oscillation in apogeotropic type of benign paroxysmal positional vertigo (BPPV) involving the horizontal semicircular canal (HC-BPPV), a randomized, prospective, sham-controlled study was conducted.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Paroxysmal Positional Vertigo
CountriesSouth Korea
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedJan 2014
Primary CompletionJul 2015
TodayJul 2026
First PostedJan 28, 2014
Enrollment StartSep 1, 2013
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.4 years ago
Interventions
Gufoniprocedure
Vibrationprocedure
Shamprocedure